| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK3 ARHGAP32 TRIO ARHGEF17 DENND4C TBC1D10B ARHGEF40 ARHGAP31 HPS4 ARFGAP1 DEF6 RIMS1 PLXNB1 TNS3 SOS1 | 3.45e-05 | 507 | 172 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK3 ARHGAP32 TRIO ARHGEF17 DENND4C TBC1D10B ARHGEF40 ARHGAP31 HPS4 ARFGAP1 DEF6 RIMS1 PLXNB1 TNS3 SOS1 | 3.45e-05 | 507 | 172 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.30e-04 | 12 | 172 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | DOCK3 ARHGAP32 TRIO KDM5A MAP3K20 WDR81 SAV1 ARHGEF17 WNK1 BIRC6 DENND4C TBC1D10B THADA ARHGEF40 ARHGAP31 HPS4 ARFGAP1 CCNL1 PHACTR4 DEF6 RIMS1 ITIH6 PLXNB1 TNS3 SOS1 LILRB4 | 2.04e-04 | 1418 | 172 | 26 | GO:0030234 |
| GeneOntologyMolecularFunction | SH3 domain binding | 2.44e-04 | 143 | 172 | 7 | GO:0017124 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | HSPG2 ARHGAP32 TRIO ATG7 MAP6 SYT17 LAMA3 NLGN1 DCC PLXNB2 ARHGEF40 HMCN2 CSPG5 CNTN5 UNC5C RIMS1 MUC3A CNTN2 PLXNB1 PLXNB3 SOS1 | 3.86e-06 | 826 | 168 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | negative regulation of pancreatic juice secretion | 5.24e-06 | 5 | 168 | 3 | GO:0090188 | |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 ARHGAP32 TRIO ATG7 MAP6 LAMA3 DCC PLXNB2 ARHGEF40 HMCN2 CNTN5 UNC5C CNTN2 PLXNB1 PLXNB3 SOS1 | 1.65e-05 | 566 | 168 | 16 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 1.81e-05 | 7 | 168 | 3 | GO:0150037 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | DOCK3 ARHGAP32 TRIO ARHGEF17 DENND4C ARHGEF40 ARHGAP31 ARFGAP1 DEF6 PLXNB1 TNS3 SOS1 | 1.92e-05 | 333 | 168 | 12 | GO:0051056 |
| GeneOntologyBiologicalProcess | axon development | HSPG2 ARHGAP32 TRIO ATG7 MAP6 LAMA3 DCC PLXNB2 ARHGEF40 HMCN2 CSPG5 CNTN5 UNC5C CNTN2 PLXNB1 PLXNB3 SOS1 | 2.05e-05 | 642 | 168 | 17 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | HSPG2 ARHGAP32 TRIO ATG7 MAP6 SYT17 LAMA3 NLGN1 DCC PLXNB2 ARHGEF40 HMCN2 CNTN5 UNC5C RIMS1 CNTN2 PLXNB1 PLXNB3 SOS1 | 3.06e-05 | 802 | 168 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell morphogenesis | BCL9L HSPG2 ARHGAP32 VPREB1 TRIO ATG7 MAP6 SYT17 LAMA3 NLGN1 DCC PLXNB2 ARHGEF40 SHROOM1 HMCN2 CSPG5 CNTN5 UNC5C RIMS1 MUC3A CNTN2 PLXNB1 PLXNB3 SOS1 | 3.84e-05 | 1194 | 168 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | central nervous system development | SOX5 HSPG2 ATG7 TSC1 TACC2 STIL DCC NRROS PLXNB2 RFX4 YWHAE TTBK1 ATXN1 MTF1 CNTN5 NCAN SYNE2 UNC5C SEC16A TACC3 TNFRSF1B QKI CNTN2 SOS1 | 4.00e-05 | 1197 | 168 | 24 | GO:0007417 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | HSPG2 ARHGAP32 TRIO ATG7 MAP6 SYT17 LAMA3 NLGN1 DCC PLXNB2 ARHGEF40 HMCN2 CNTN5 UNC5C RIMS1 CNTN2 PLXNB1 PLXNB3 SOS1 | 4.06e-05 | 819 | 168 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of pancreatic juice secretion | 4.30e-05 | 9 | 168 | 3 | GO:0090186 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.20e-04 | 285 | 168 | 10 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.23e-04 | 286 | 168 | 10 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HSPG2 ARHGAP32 TRIO ATG7 MAP6 LAMA3 NLGN1 DCC PLXNB2 ARHGEF40 HMCN2 CNTN5 UNC5C CNTN2 PLXNB1 PLXNB3 SOS1 | 1.35e-04 | 748 | 168 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 1.43e-04 | 13 | 168 | 3 | GO:0031632 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle membrane organization | 1.43e-04 | 13 | 168 | 3 | GO:1901634 | |
| GeneOntologyBiologicalProcess | calcium-dependent activation of synaptic vesicle fusion | 1.43e-04 | 13 | 168 | 3 | GO:0099502 | |
| GeneOntologyBiologicalProcess | pancreatic juice secretion | 1.81e-04 | 14 | 168 | 3 | GO:0030157 | |
| GeneOntologyBiologicalProcess | negative regulation of plasma cell differentiation | 1.97e-04 | 3 | 168 | 2 | GO:1900099 | |
| GeneOntologyBiologicalProcess | gliogenesis | SOX5 NRROS TTBK1 NDRG1 ATXN1 CSPG5 NCAN SYNE2 TNFRSF1B QKI CNTN2 SOS1 | 2.43e-04 | 435 | 168 | 12 | GO:0042063 |
| GeneOntologyBiologicalProcess | intracellular chloride ion homeostasis | 2.75e-04 | 16 | 168 | 3 | GO:0030644 | |
| GeneOntologyBiologicalProcess | neuron projection development | HSPG2 ARHGAP32 TRIO ATG7 MAP6 SYT17 LAMA3 TSC1 NLGN1 DCC PLXNB2 ARHGEF40 HMCN2 CSPG5 CNTN5 UNC5C RIMS1 QKI CNTN2 PLXNB1 PLXNB3 OTOG SOS1 | 3.12e-04 | 1285 | 168 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | glial cell differentiation | 3.12e-04 | 321 | 168 | 10 | GO:0010001 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic anion homeostasis | 3.32e-04 | 17 | 168 | 3 | GO:0030002 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 3.78e-04 | 116 | 168 | 6 | GO:0008344 | |
| GeneOntologyBiologicalProcess | vitellogenesis | 3.91e-04 | 4 | 168 | 2 | GO:0007296 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 7.40e-05 | 164 | 175 | 8 | GO:0098982 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.55e-04 | 13 | 175 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.14e-04 | 109 | 175 | 6 | GO:0005796 | |
| Domain | OSR1_C | 1.53e-05 | 6 | 173 | 3 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.53e-05 | 6 | 173 | 3 | IPR024678 | |
| Domain | Plexin_cytopl | 6.30e-05 | 9 | 173 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 6.30e-05 | 9 | 173 | 3 | IPR013548 | |
| Domain | Plexin | 6.30e-05 | 9 | 173 | 3 | IPR031148 | |
| Domain | Znf_FYVE_PHD | 6.88e-05 | 147 | 173 | 8 | IPR011011 | |
| Domain | Distrobrevin | 8.53e-05 | 2 | 173 | 2 | IPR017432 | |
| Domain | FAM78 | 8.53e-05 | 2 | 173 | 2 | IPR029638 | |
| Domain | PHD | 1.78e-04 | 89 | 173 | 6 | SM00249 | |
| Domain | Znf_PHD | 2.01e-04 | 91 | 173 | 6 | IPR001965 | |
| Domain | TACC | 2.54e-04 | 3 | 173 | 2 | PF05010 | |
| Domain | TACC | 2.54e-04 | 3 | 173 | 2 | IPR007707 | |
| Domain | ZF_PHD_2 | 2.55e-04 | 95 | 173 | 6 | PS50016 | |
| Domain | SEA | 2.64e-04 | 14 | 173 | 3 | SM00200 | |
| Domain | ZF_PHD_1 | 2.70e-04 | 96 | 173 | 6 | PS01359 | |
| Domain | Ig-like_fold | HSPG2 VPREB1 TRIO DCC PLXNB2 IL22RA1 FNDC1 HMCN2 CNTN5 NCAN UNC5C CD300LG ADGRF3 CNTN2 PLXNB1 PLXNB3 LILRB4 | 3.10e-04 | 706 | 173 | 17 | IPR013783 |
| Domain | Lys_sp_deMease-like_dom | 5.06e-04 | 4 | 173 | 2 | IPR013637 | |
| Domain | PLU-1 | 5.06e-04 | 4 | 173 | 2 | PF08429 | |
| Domain | EGF-like_dom | 5.36e-04 | 249 | 173 | 9 | IPR000742 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 6.79e-04 | 19 | 173 | 3 | IPR006553 | |
| Domain | LRR_CC | 6.79e-04 | 19 | 173 | 3 | SM00367 | |
| Domain | Znf_PHD-finger | 8.34e-04 | 79 | 173 | 5 | IPR019787 | |
| Domain | Biotin_BS | 8.38e-04 | 5 | 173 | 2 | IPR001882 | |
| Domain | Biotin_COase_C | 8.38e-04 | 5 | 173 | 2 | IPR005482 | |
| Domain | BC | 8.38e-04 | 5 | 173 | 2 | PS50979 | |
| Domain | zf-C5HC2 | 8.38e-04 | 5 | 173 | 2 | PF02928 | |
| Domain | Biotin_carb_C | 8.38e-04 | 5 | 173 | 2 | SM00878 | |
| Domain | Biotin_carb_C | 8.38e-04 | 5 | 173 | 2 | PF02785 | |
| Domain | Biotin_carboxylation_dom | 8.38e-04 | 5 | 173 | 2 | IPR011764 | |
| Domain | Znf_C5HC2 | 8.38e-04 | 5 | 173 | 2 | IPR004198 | |
| Domain | BIOTIN | 8.38e-04 | 5 | 173 | 2 | PS00188 | |
| Domain | SEA | 1.21e-03 | 23 | 173 | 3 | PS50024 | |
| Domain | SEA_dom | 1.21e-03 | 23 | 173 | 3 | IPR000082 | |
| Domain | Rudment_hybrid_motif | 1.25e-03 | 6 | 173 | 2 | IPR011054 | |
| Domain | CPSASE_2 | 1.25e-03 | 6 | 173 | 2 | PS00867 | |
| Domain | EF-hand_dom_typ1 | 1.25e-03 | 6 | 173 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.25e-03 | 6 | 173 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 1.25e-03 | 6 | 173 | 2 | PF09068 | |
| Domain | EF-hand_3 | 1.25e-03 | 6 | 173 | 2 | PF09069 | |
| Domain | - | HSPG2 VPREB1 TRIO DCC PLXNB2 IL22RA1 FNDC1 CNTN5 NCAN UNC5C CD300LG CNTN2 PLXNB1 PLXNB3 LILRB4 | 1.31e-03 | 663 | 173 | 15 | 2.60.40.10 |
| Domain | Rho_GTPase_activation_prot | 1.36e-03 | 88 | 173 | 5 | IPR008936 | |
| Domain | JmjC | 1.37e-03 | 24 | 173 | 3 | PF02373 | |
| Domain | EGF_3 | 1.59e-03 | 235 | 173 | 8 | PS50026 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 1.74e-03 | 7 | 173 | 2 | IPR005479 | |
| Domain | BC-like_N | 1.74e-03 | 7 | 173 | 2 | IPR005481 | |
| Domain | CPSase_L_D2 | 1.74e-03 | 7 | 173 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 1.74e-03 | 7 | 173 | 2 | PF00289 | |
| Domain | Ser/Thr_kinase_AS | 1.86e-03 | 357 | 173 | 10 | IPR008271 | |
| Domain | IG | HSPG2 VPREB1 TRIO DCC HMCN2 CNTN5 NCAN UNC5C CD300LG CNTN2 LILRB4 | 1.93e-03 | 421 | 173 | 11 | SM00409 |
| Domain | Ig_sub | HSPG2 VPREB1 TRIO DCC HMCN2 CNTN5 NCAN UNC5C CD300LG CNTN2 LILRB4 | 1.93e-03 | 421 | 173 | 11 | IPR003599 |
| Domain | IPT | 1.94e-03 | 27 | 173 | 3 | SM00429 | |
| Domain | S_TKc | 1.94e-03 | 359 | 173 | 10 | SM00220 | |
| Domain | Ig_I-set | 1.99e-03 | 190 | 173 | 7 | IPR013098 | |
| Domain | I-set | 1.99e-03 | 190 | 173 | 7 | PF07679 | |
| Domain | PROTEIN_KINASE_ST | 2.06e-03 | 362 | 173 | 10 | PS00108 | |
| Domain | LAMININ_IVA | 2.30e-03 | 8 | 173 | 2 | PS51115 | |
| Domain | Laminin_B | 2.30e-03 | 8 | 173 | 2 | PF00052 | |
| Domain | LamB | 2.30e-03 | 8 | 173 | 2 | SM00281 | |
| Domain | Laminin_IV | 2.30e-03 | 8 | 173 | 2 | IPR000034 | |
| Domain | EGF_LAM_2 | 2.64e-03 | 30 | 173 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 2.64e-03 | 30 | 173 | 3 | PS01248 | |
| Domain | EGF_1 | 2.65e-03 | 255 | 173 | 8 | PS00022 | |
| Domain | DH_1 | 2.77e-03 | 63 | 173 | 4 | PS00741 | |
| Domain | Semap_dom | 2.90e-03 | 31 | 173 | 3 | IPR001627 | |
| Domain | SEMA | 2.90e-03 | 31 | 173 | 3 | PS51004 | |
| Domain | TIG | 2.90e-03 | 31 | 173 | 3 | PF01833 | |
| Domain | Sema | 2.90e-03 | 31 | 173 | 3 | SM00630 | |
| Domain | Sema | 2.90e-03 | 31 | 173 | 3 | PF01403 | |
| Domain | Biotin_lipoyl | 2.94e-03 | 9 | 173 | 2 | PF00364 | |
| Domain | EGF-like_CS | 3.05e-03 | 261 | 173 | 8 | IPR013032 | |
| Domain | Zinc_finger_PHD-type_CS | 3.10e-03 | 65 | 173 | 4 | IPR019786 | |
| Domain | IPT | 3.18e-03 | 32 | 173 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 3.18e-03 | 32 | 173 | 3 | IPR002165 | |
| Domain | PSI | 3.18e-03 | 32 | 173 | 3 | PF01437 | |
| Domain | JMJC | 3.18e-03 | 32 | 173 | 3 | PS51184 | |
| Domain | JmjC_dom | 3.18e-03 | 32 | 173 | 3 | IPR003347 | |
| Domain | EGF_2 | 3.34e-03 | 265 | 173 | 8 | PS01186 | |
| Domain | JmjC | 3.47e-03 | 33 | 173 | 3 | SM00558 | |
| Domain | JmjN | 3.66e-03 | 10 | 173 | 2 | SM00545 | |
| Domain | JmjN | 3.66e-03 | 10 | 173 | 2 | PF02375 | |
| Domain | BIOTINYL_LIPOYL | 3.66e-03 | 10 | 173 | 2 | PS50968 | |
| Domain | JMJN | 3.66e-03 | 10 | 173 | 2 | PS51183 | |
| Domain | EF-hand_4 | 3.66e-03 | 10 | 173 | 2 | PF12763 | |
| Domain | Biotin_lipoyl | 3.66e-03 | 10 | 173 | 2 | IPR000089 | |
| Domain | JmjN | 3.66e-03 | 10 | 173 | 2 | IPR003349 | |
| Domain | Znf_FYVE-rel | 3.78e-03 | 34 | 173 | 3 | IPR017455 | |
| Domain | RhoGEF | 4.05e-03 | 70 | 173 | 4 | PF00621 | |
| Domain | DH_2 | 4.05e-03 | 70 | 173 | 4 | PS50010 | |
| Domain | EGF_Lam | 4.11e-03 | 35 | 173 | 3 | SM00180 | |
| Domain | Laminin_EGF | 4.11e-03 | 35 | 173 | 3 | PF00053 | |
| Domain | - | 4.26e-03 | 71 | 173 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 4.26e-03 | 71 | 173 | 4 | IPR000219 | |
| Domain | - | 4.27e-03 | 218 | 173 | 7 | 1.10.10.10 | |
| Domain | Hist_deacetyl | 4.44e-03 | 11 | 173 | 2 | PF00850 | |
| Domain | PNT | 4.44e-03 | 11 | 173 | 2 | PS51433 | |
| Domain | SAM_PNT | 4.44e-03 | 11 | 173 | 2 | PF02198 | |
| Domain | - | 4.44e-03 | 11 | 173 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse_dom | 4.44e-03 | 11 | 173 | 2 | IPR023801 | |
| Domain | EH | 4.44e-03 | 11 | 173 | 2 | PS50031 | |
| Domain | Pointed_dom | 4.44e-03 | 11 | 173 | 2 | IPR003118 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B ARHGAP32 TRIO KDM5A ERC1 MAP3K20 MCCC1 STIL LARP1B ARHGEF17 WNK1 YWHAE DENND4C MLXIPL TBC1D10B NDRG1 MYLK3 TCERG1 ATXN1 PRRC2C SVIL SYNE2 ARFGAP1 PHACTR4 LPP SEC16A MAP2K7 BICC1 WNK3 TNS3 OTOG CCDC102A | 1.76e-18 | 861 | 179 | 32 | 36931259 |
| Pubmed | SOX5 BCL9L HSPG2 ARHGAP32 FOXK2 HDAC5 ACACB VEZF1 KDM5A DTNA ETV7 YY2 HIPK2 ETV6 MCCC1 RAD54L2 ZHX2 ANKHD1 TRIM24 NOSIP MED15 BBX TCERG1 ATXN1 PRRC2C MDC1 SVIL SYNE2 ARFGAP1 SEC16A NFYC PABPC1L MRTO4 EIF3A QKI SAP130 NPAT RAVER1 | 5.35e-17 | 1429 | 179 | 38 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 BCL9L FOXK2 HDAC5 ACACB KDM5A RAD54L2 ZHX2 TRIM24 MED15 TNRC18 ATXN1 MDC1 SEC16A RAI1 | 4.97e-10 | 351 | 179 | 15 | 38297188 |
| Pubmed | EPS15 KDM5B HDAC5 ACACB ZFYVE16 KDM5A ERC1 MCCC1 ANKHD1 TRIM24 BIRC6 DENND4C SEC16A KIAA1958 TACC3 NPAT | 6.37e-10 | 418 | 179 | 16 | 34709266 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | IKZF2 HDAC5 KDM5A ETV6 YWHAE TNRC18 BBX SVIL SYNE2 SEC16A HDAC10 SAP130 | 3.90e-08 | 289 | 179 | 12 | 23752268 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK3 EPS15 ARHGAP32 HDAC5 ACACB RAD54L2 GRM1 WNK1 TNRC18 ARHGAP31 UBQLN3 MDC1 SAP130 SOS1 | 5.87e-08 | 430 | 179 | 14 | 35044719 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | EPS15 REPS1 TACC2 MCCC1 RAD54L2 ZHX2 TRIM24 NOSIP MED15 TCERG1 ARFGAP1 LPP SEC16A CCDC102A | 8.69e-08 | 444 | 179 | 14 | 34795231 |
| Pubmed | EPS15 ARHGAP32 TRIO MAP6 KDM5A ERC1 WDR81 TSC1 GRM1 YWHAE NOSIP PRRC2C NCAN SVIL SYNE2 SEC16A RIMS1 TACC3 WNK3 RAI1 | 1.42e-07 | 963 | 179 | 20 | 28671696 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SOX5 FOXK2 QPCTL VEZF1 ZHX2 TRIM24 MED15 TNRC18 SYNE2 SEC16A NFYC KDM2A ZNF292 | 1.71e-07 | 398 | 179 | 13 | 35016035 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EPS15 FOXK2 TRIO ATG7 DTNA DTNB POLG HIPK2 LAMA3 CILK1 POMT1 ZHX2 YWHAE THADA TNRC18 NDRG1 ATXN1 LPP NLRC5 KDM2A RIMS1 ZSWIM4 SAP130 RAI1 RAVER1 | 2.07e-07 | 1489 | 179 | 25 | 28611215 |
| Pubmed | ARHGAP32 HIPK2 LAMA3 NCKAP5 WNK1 YWHAE TCERG1 ATXN1 ARHGAP31 HPS4 NFYC KDM2A EIF3A SOS1 | 2.60e-07 | 486 | 179 | 14 | 20936779 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 HSPG2 CRYBG2 FOXK2 REPS1 TRIO POLG TASP1 ANKHD1 WNK1 PLXNB2 BIRC6 FOCAD PIKFYVE THADA TNRC18 ARHGEF40 DEF6 SEC16A NLRC5 RAI1 | 2.94e-07 | 1105 | 179 | 21 | 35748872 |
| Pubmed | DOCK3 ARHGAP32 BAZ2B CILK1 VARS2 WNK1 BIRC6 PIKFYVE THADA TNRC18 TTBK1 SCAPER KDM2A EIF3A | 3.09e-07 | 493 | 179 | 14 | 15368895 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 4.35e-07 | 180 | 179 | 9 | 35198878 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HDAC5 ERC1 DTNA HIPK2 TSC1 TACC2 MCCC1 RAD54L2 WNK1 NOSIP PIKFYVE TCERG1 PRRC2C SEC16A MED25 | 4.50e-07 | 588 | 179 | 15 | 38580884 |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 15147296 | ||
| Pubmed | 6.79e-07 | 60 | 179 | 6 | 34761192 | ||
| Pubmed | DOCK3 KDM5B REPS1 TRIO KDM5A ERC1 POLG NCKAP5 RAD54L2 YWHAE STAB1 FOCAD DGLUCY NDRG1 TCERG1 HPS4 QKI YME1L1 MTUS2 PLXNB3 ZNF292 SOS1 | 8.65e-07 | 1285 | 179 | 22 | 35914814 | |
| Pubmed | REPS1 ERC1 ANKHD1 MED15 TCERG1 PRRC2C MDC1 ARFGAP1 PHACTR4 LPP SEC16A KDM2A TACC3 SAP130 | 1.11e-06 | 549 | 179 | 14 | 38280479 | |
| Pubmed | 1.19e-06 | 104 | 179 | 7 | 9205841 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 12183458 | ||
| Pubmed | Interplay between scatter factor receptors and B plexins controls invasive growth. | 1.33e-06 | 5 | 179 | 3 | 15184888 | |
| Pubmed | WNK kinases sense molecular crowding and rescue cell volume via phase separation. | 1.33e-06 | 5 | 179 | 3 | 36318922 | |
| Pubmed | BCL9L TRIO POMT1 FAM78A TNRC18 PRRC2C SVIL SEC16A KDM2A TACC3 TNS3 | 1.35e-06 | 332 | 179 | 11 | 37433992 | |
| Pubmed | DOCK3 EPS15 ARHGAP32 REPS1 QPCTL TRIO DTNA MCCC1 ARHGEF17 NOSIP ARHGEF40 TCERG1 ARHGAP31 SEC16A LSM11 YME1L1 SOS1 RAVER1 | 1.37e-06 | 916 | 179 | 18 | 32203420 | |
| Pubmed | HSPG2 REPS1 TRIO KDM5A DTNA WNK1 BIRC6 YWHAE ATXN1 SYNE2 KDM2A MRTO4 EIF3A | 2.05e-06 | 497 | 179 | 13 | 23414517 | |
| Pubmed | EPS15 FOXK2 ERC1 MAP3K20 TACC2 WNK1 DENND4C NDRG1 ARFGAP1 SEC16A STK39 TACC3 RAVER1 | 2.34e-06 | 503 | 179 | 13 | 16964243 | |
| Pubmed | FOXK2 REPS1 QPCTL VEZF1 KDM5A SMARCAL1 MAP3K20 TASP1 NOL11 VARS2 LARP1B ANKHD1 YWHAE NOSIP TBC1D10B ARHGEF40 TCERG1 PRRC2C SVIL SEC16A MRTO4 QKI | 2.49e-06 | 1371 | 179 | 22 | 36244648 | |
| Pubmed | 2.77e-06 | 225 | 179 | 9 | 12168954 | ||
| Pubmed | BCL9L EPS15 FOXK2 REPS1 QPCTL VEZF1 KDM5A MAP3K20 TASP1 NOL11 ETV6 ZHX2 ANKHD1 YWHAE MED15 BBX TCERG1 MDC1 CCNL1 MED25 LSM11 EIF3A YME1L1 | 2.97e-06 | 1497 | 179 | 23 | 31527615 | |
| Pubmed | 3.31e-06 | 230 | 179 | 9 | 35449600 | ||
| Pubmed | 3.68e-06 | 233 | 179 | 9 | 37704626 | ||
| Pubmed | EPS15 ARHGAP32 REPS1 ZFYVE16 ERC1 DTNA YWHAE DENND4C TBC1D10B NDRG1 TCERG1 PRRC2C ARFGAP1 PHACTR4 SEC16A | 4.41e-06 | 708 | 179 | 15 | 39231216 | |
| Pubmed | 4.62e-06 | 7 | 179 | 3 | 24449837 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 4.62e-06 | 7 | 179 | 3 | 35176221 | |
| Pubmed | FOXK2 VEZF1 BAZ2B ETV6 RAD54L2 TRIM24 NOSIP MED15 TNRC18 TCERG1 PRRC2C KIAA1958 MRTO4 QKI MAP2K7 SAP130 RAI1 ZNF292 RAVER1 | 4.66e-06 | 1103 | 179 | 19 | 34189442 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L FOXK2 RBMS2 ANKHD1 TRIM24 MED15 PRRC2C SEC16A SAP130 BICC1 RAI1 RAVER1 | 4.93e-06 | 457 | 179 | 12 | 32344865 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 5.44e-06 | 184 | 179 | 8 | 32908313 | |
| Pubmed | FOXK2 REPS1 TRIO ZFYVE16 YWHAE NDRG1 CCNL1 SEC16A KDM2A TACC3 SAP130 TNS3 | 6.83e-06 | 472 | 179 | 12 | 38943005 | |
| Pubmed | 7.30e-06 | 52 | 179 | 5 | 26633812 | ||
| Pubmed | DOCK3 CACNA1B BCL9L ARHGAP32 ACACB TRIO MAP6 ERC1 DTNA TACC2 MCCC1 BIRC6 YWHAE TNRC18 NDRG1 PRRC2C AJM1 ARFGAP1 RIMS1 | 7.34e-06 | 1139 | 179 | 19 | 36417873 | |
| Pubmed | 7.37e-06 | 8 | 179 | 3 | 15661641 | ||
| Pubmed | IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway. | 7.37e-06 | 8 | 179 | 3 | 21317537 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPS15 REPS1 ACACB ZFYVE16 ERC1 TSC1 TACC2 MCCC1 ANKHD1 WNK1 NDRG1 TCERG1 PRRC2C ARFGAP1 LPP SEC16A EIF3A | 7.46e-06 | 934 | 179 | 17 | 33916271 |
| Pubmed | FOXK2 ERC1 ZHX2 WNK1 TCERG1 PRRC2C MDC1 SEC16A TACC3 QKI SAP130 | 7.83e-06 | 399 | 179 | 11 | 35987950 | |
| Pubmed | ARHGAP32 TRIO ZFYVE16 ERC1 DTNA DTNB TSC1 BIRC6 YWHAE TBC1D10B CSPG5 SVIL SYNE2 LPP SEC16A YME1L1 TNS3 RAVER1 | 8.86e-06 | 1049 | 179 | 18 | 27880917 | |
| Pubmed | HDAC5 ZFYVE16 ERC1 TSC1 NLGN1 ZHX2 ARHGEF17 FOCAD PRRC2C SEC16A PLXNB3 | 9.43e-06 | 407 | 179 | 11 | 12693553 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | VEZF1 BAZ2B RBMS2 YY2 NOL11 MCCC1 TRIM24 YWHAE NOSIP BBX TCERG1 PRRC2C MDC1 SEC16A SAP130 RAI1 NPAT | 9.81e-06 | 954 | 179 | 17 | 36373674 |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 1.04e-05 | 265 | 179 | 9 | 19240061 | |
| Pubmed | 1.14e-05 | 268 | 179 | 9 | 33640491 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM5A TBC1D10B NDRG1 MDC1 SVIL ARFGAP1 CCNL1 PHACTR4 SEC16A KIAA1958 RIMS1 TACC3 MN1 SOS1 RAVER1 | 1.27e-05 | 774 | 179 | 15 | 15302935 |
| Pubmed | 1.38e-05 | 209 | 179 | 8 | 36779422 | ||
| Pubmed | 1.91e-05 | 360 | 179 | 10 | 33111431 | ||
| Pubmed | 1.92e-05 | 31 | 179 | 4 | 29099309 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | DOCK3 BCL9L ERC1 MAP3K20 SHROOM1 HMCN2 PRRC2C MDC1 EIF3A TNS3 | 1.96e-05 | 361 | 179 | 10 | 26167880 |
| Pubmed | 2.01e-05 | 107 | 179 | 6 | 11347906 | ||
| Pubmed | KDM5A ERC1 ANKHD1 TRIM24 YWHAE TBC1D10B THADA ARHGEF40 HMCN2 ATXN1 SEC16A SCAPER STK39 MAP2K7 YME1L1 SAP130 RAI1 SOS1 | 2.02e-05 | 1116 | 179 | 18 | 31753913 | |
| Pubmed | SOX5 KDM5B IKZF2 FOXK2 VEZF1 ETV6 TACC2 BIRC6 PIKFYVE NDRG1 MTF1 TACC3 POU2F3 ZNF292 | 2.03e-05 | 709 | 179 | 14 | 22988430 | |
| Pubmed | SOX5 KDM5B IKZF2 VEZF1 KDM5A ETV6 TRIM24 BBX ATXN1 MTF1 LPP SCAPER NFYC POU2F3 ZNF292 | 2.09e-05 | 808 | 179 | 15 | 20412781 | |
| Pubmed | Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. | 2.15e-05 | 11 | 179 | 3 | 15186747 | |
| Pubmed | BCL9L HDAC5 ACACB ERC1 MAP3K20 SAV1 WNK1 BIRC6 YWHAE DENND4C SEC16A | 2.20e-05 | 446 | 179 | 11 | 24255178 | |
| Pubmed | Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks. | 2.47e-05 | 111 | 179 | 6 | 22558309 | |
| Pubmed | 2.62e-05 | 298 | 179 | 9 | 30737378 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 23437357 | ||
| Pubmed | unc5c haploinsufficient phenotype: striking similarities with the dcc haploinsufficiency model. | 2.63e-05 | 2 | 179 | 2 | 23738838 | |
| Pubmed | Functional regulation of semaphorin receptors by proprotein convertases. | 2.63e-05 | 2 | 179 | 2 | 12533544 | |
| Pubmed | STK39 and WNK1 Are Potential Hypertension Susceptibility Genes in the BELHYPGEN Cohort. | 2.63e-05 | 2 | 179 | 2 | 27082544 | |
| Pubmed | Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases. | 2.63e-05 | 2 | 179 | 2 | 29273914 | |
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 2.63e-05 | 2 | 179 | 2 | 10973822 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 7731705 | ||
| Pubmed | Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer. | 2.63e-05 | 2 | 179 | 2 | 18054557 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11847113 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 30917032 | ||
| Pubmed | KDM5 lysine demethylases are involved in maintenance of 3'UTR length. | 2.63e-05 | 2 | 179 | 2 | 28138513 | |
| Pubmed | Genetic and environmental risk factors for submucous cleft palate. | 2.63e-05 | 2 | 179 | 2 | 22409215 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 19242752 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 8663515 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 12958310 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 30472020 | ||
| Pubmed | Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6. | 2.63e-05 | 2 | 179 | 2 | 11108721 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21245341 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 9334251 | ||
| Pubmed | Muscular dystrophies and the dystrophin-glycoprotein complex. | 2.63e-05 | 2 | 179 | 2 | 9146999 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 34184733 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 2.63e-05 | 2 | 179 | 2 | 2393399 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11289722 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 36509829 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 28945285 | ||
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 2.63e-05 | 2 | 179 | 2 | 10405327 | |
| Pubmed | TACC3 expression is tightly regulated during early differentiation. | 2.63e-05 | 2 | 179 | 2 | 12711550 | |
| Pubmed | 2.85e-05 | 12 | 179 | 3 | 27782176 | ||
| Pubmed | Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. | 2.85e-05 | 12 | 179 | 3 | 12123608 | |
| Pubmed | 2.85e-05 | 12 | 179 | 3 | 20478304 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 2.85e-05 | 12 | 179 | 3 | 21270798 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EPS15 FOXK2 HDAC5 RBMS2 MAP3K20 WDR81 WNK1 DENND4C MLXIPL SHROOM1 ARFGAP1 LPP SEC16A PABPC1L LSM11 MAP2K7 TNS3 | 2.87e-05 | 1038 | 179 | 17 | 26673895 |
| Pubmed | ARHGAP32 ACACB SMARCAL1 YY2 NRROS TRIM24 NOSIP MED15 SYNE2 UNC5C YME1L1 RAI1 RAVER1 | 2.92e-05 | 638 | 179 | 13 | 31182584 | |
| Pubmed | 3.69e-05 | 13 | 179 | 3 | 24572910 | ||
| Pubmed | 3.69e-05 | 13 | 179 | 3 | 21844884 | ||
| Pubmed | 3.69e-05 | 13 | 179 | 3 | 10520995 | ||
| Pubmed | 3.69e-05 | 13 | 179 | 3 | 19805522 | ||
| Interaction | YWHAH interactions | KDM5B ARHGAP32 HDAC5 TRIO KDM5A ERC1 MAP3K20 PLEKHA4 SAV1 TSC1 STIL LARP1B ARHGEF17 WNK1 YWHAE DENND4C MLXIPL TBC1D10B SHROOM1 NDRG1 TCERG1 ATXN1 PRRC2C SVIL SYNE2 RECQL4 ARFGAP1 PHACTR4 LPP SEC16A RIMS1 BICC1 WNK3 FRMD5 TNS3 OTOG | 4.23e-12 | 1102 | 175 | 36 | int:YWHAH |
| Interaction | WNK3 interactions | 2.74e-08 | 56 | 175 | 8 | int:WNK3 | |
| Interaction | ZYX interactions | DOCK3 ARHGAP32 FOXK2 PLEKHA4 HIPK2 WNK1 YWHAE TBC1D10B ATXN1 ARHGAP31 SVIL LPP SEC16A TACC3 WNK3 | 1.97e-07 | 329 | 175 | 15 | int:ZYX |
| Interaction | YWHAG interactions | KDM5B ARHGAP32 HDAC5 ERC1 MAP3K20 PLEKHA4 TSC1 LARP1B ARHGEF17 WNK1 YWHAE DENND4C MLXIPL TBC1D10B SHROOM1 TTBK1 NDRG1 TCERG1 ATXN1 PRRC2C SVIL SYNE2 RECQL4 PHACTR4 SEC16A BICC1 FRMD5 TNS3 OTOG CCDC102A | 3.49e-07 | 1248 | 175 | 30 | int:YWHAG |
| Interaction | PFN1 interactions | EPS15 HDAC5 TRIO ATG7 ERC1 PLEKHA4 TSC1 ANKHD1 WNK1 TRIM24 BIRC6 DENND4C THADA SYNE2 RECQL4 LPP SEC16A | 2.29e-06 | 509 | 175 | 17 | int:PFN1 |
| Interaction | HDAC1 interactions | EPS15 KDM5B IKZF2 FOXK2 HDAC5 ACACB ZFYVE16 KDM5A ERC1 PLEKHA4 MCCC1 ZHX2 ANKHD1 BIRC6 YWHAE DENND4C TNRC18 BBX ATXN1 SYNE2 RECQL4 NFYC TACC3 SAP130 RAI1 NPAT | 3.63e-06 | 1108 | 175 | 26 | int:HDAC1 |
| Interaction | FHL2 interactions | FOXK2 PLEKHA4 HIPK2 WNK1 YWHAE TNRC18 BBX ATXN1 PRRC2C LPP NFYC SAP130 WNK3 RAVER1 | 9.86e-06 | 396 | 175 | 14 | int:FHL2 |
| Interaction | SNRNP40 interactions | BCL9L HSPG2 ACACB VEZF1 BAZ2B SMARCAL1 PLEKHA4 NOL11 ETV6 ZHX2 TRIM24 NOSIP TCERG1 MDC1 KDM2A QKI NPAT RAVER1 | 1.15e-05 | 637 | 175 | 18 | int:SNRNP40 |
| Interaction | RUNDC3A interactions | 1.77e-05 | 63 | 175 | 6 | int:RUNDC3A | |
| Interaction | LMO2 interactions | SOX5 KDM5B HDAC5 VEZF1 KDM5A HIPK2 TSC1 YWHAE LYL1 MN1 MTUS2 RAI1 | 1.78e-05 | 310 | 175 | 12 | int:LMO2 |
| Interaction | PML interactions | EPS15 REPS1 PLEKHA4 HIPK2 TACC2 RAD54L2 ZHX2 TRIM24 NOSIP MED15 TCERG1 ATXN1 MDC1 SYNE2 ARFGAP1 LPP SEC16A MRTO4 STK39 EIF3A SAP130 CCDC102A | 2.04e-05 | 933 | 175 | 22 | int:PML |
| Interaction | RCOR1 interactions | SOX5 EPS15 KDM5B FOXK2 HDAC5 ACACB ZFYVE16 ERC1 MCCC1 ANKHD1 BIRC6 DENND4C RECQL4 SEC16A NPAT | 2.82e-05 | 494 | 175 | 15 | int:RCOR1 |
| Interaction | HNRNPCL2 interactions | FOXK2 KDM5A PLEKHA4 LARP1B RAD54L2 ARHGEF40 BBX PHACTR4 STK39 QKI MAP2K7 | 2.88e-05 | 274 | 175 | 11 | int:HNRNPCL2 |
| Interaction | WNK2 interactions | 3.06e-05 | 42 | 175 | 5 | int:WNK2 | |
| Interaction | BAG2 interactions | HDAC5 POLG PLEKHA4 STIL ANKHD1 WNK1 SHROOM1 ATXN1 PRRC2C MDC1 RECQL4 PHACTR4 NFYC TACC3 QKI WNK3 RAVER1 | 3.12e-05 | 622 | 175 | 17 | int:BAG2 |
| Interaction | RBBP7 interactions | KDM5B FOXK2 HDAC5 ACACB KDM5A BAZ2B PLEKHA4 ZHX2 ANKHD1 BIRC6 TNRC18 ATXN1 RECQL4 SAP130 NPAT | 3.80e-05 | 507 | 175 | 15 | int:RBBP7 |
| Interaction | RBBP4 interactions | KDM5B FOXK2 HDAC5 ACACB KDM5A PLEKHA4 ZHX2 YWHAE MED15 TNRC18 BBX ATXN1 RECQL4 SAP130 RAI1 NPAT | 4.17e-05 | 573 | 175 | 16 | int:RBBP4 |
| Interaction | PHF21A interactions | EPS15 HDAC5 ACACB ZFYVE16 ERC1 MCCC1 ANKHD1 BIRC6 DENND4C SEC16A TACC3 NPAT | 4.79e-05 | 343 | 175 | 12 | int:PHF21A |
| Interaction | KLF15 interactions | VEZF1 TRIM24 MED15 PRRC2C SEC16A NFYC KDM2A MRTO4 EIF3A SAP130 ZNF292 | 4.82e-05 | 290 | 175 | 11 | int:KLF15 |
| Interaction | EIF4ENIF1 interactions | RBMS2 SAV1 ANKHD1 TRIM24 ATXN1 PRRC2C DEF6 SEC16A EIF3A QKI BICC1 | 6.54e-05 | 300 | 175 | 11 | int:EIF4ENIF1 |
| Interaction | CRX interactions | 7.85e-05 | 254 | 175 | 10 | int:CRX | |
| Interaction | PTPN23 interactions | 8.74e-05 | 162 | 175 | 8 | int:PTPN23 | |
| Interaction | NUP35 interactions | BCL9L FOXK2 RBMS2 PLEKHA4 ANKHD1 TRIM24 MED15 PRRC2C SEC16A SAP130 BICC1 RAI1 RAVER1 | 8.88e-05 | 424 | 175 | 13 | int:NUP35 |
| Interaction | SEC16A interactions | DOCK3 ARHGAP32 ATG7 PLEKHA4 SAV1 ETV6 STIL ANKHD1 PRRC2C RECQL4 SEC16A MAP2K7 WNK3 | 9.31e-05 | 426 | 175 | 13 | int:SEC16A |
| Interaction | DCAF7 interactions | SOX5 QPCTL RBMS2 SMARCAL1 PLEKHA4 HIPK2 RAD54L2 YWHAE ATXN1 SVIL RECQL4 MAP2K7 | 9.36e-05 | 368 | 175 | 12 | int:DCAF7 |
| Interaction | RNF43 interactions | KDM5B ARHGAP32 ZFYVE16 RBMS2 TRIM24 YWHAE TCERG1 SVIL ARFGAP1 LPP SEC16A QKI YME1L1 | 9.53e-05 | 427 | 175 | 13 | int:RNF43 |
| Interaction | TBPL2 interactions | 1.01e-04 | 11 | 175 | 3 | int:TBPL2 | |
| Interaction | YWHAQ interactions | KDM5B ARHGAP32 HDAC5 ERC1 MAP3K20 PLEKHA4 TSC1 MCCC1 LARP1B ZHX2 WNK1 YWHAE DENND4C MLXIPL SHROOM1 ATXN1 SVIL RECQL4 PHACTR4 BICC1 FRMD5 TNS3 OTOG | 1.07e-04 | 1118 | 175 | 23 | int:YWHAQ |
| Interaction | TLE3 interactions | BCL9L VEZF1 BAZ2B ETV6 RAD54L2 MED15 TNRC18 NDRG1 ATXN1 QKI SAP130 RAVER1 | 1.15e-04 | 376 | 175 | 12 | int:TLE3 |
| Interaction | EGR2 interactions | 1.27e-04 | 171 | 175 | 8 | int:EGR2 | |
| Interaction | RAC1 interactions | DOCK3 ARHGAP32 TRIO ZFYVE16 DTNA PLEKHA4 TSC1 PLXNB2 DENND4C PIKFYVE TBC1D10B ARHGEF40 ATXN1 ARHGAP31 HPS4 PHACTR4 DEF6 STK39 YME1L1 PLXNB1 TNS3 SOS1 | 1.40e-04 | 1063 | 175 | 22 | int:RAC1 |
| Interaction | PAX9 interactions | 1.42e-04 | 130 | 175 | 7 | int:PAX9 | |
| Interaction | ABI1 interactions | 1.49e-04 | 223 | 175 | 9 | int:ABI1 | |
| Interaction | DTX2 interactions | BCL9L ARHGAP32 ARMC7 ACACB MCCC1 RAD54L2 MED15 MDC1 SEC16A RAI1 RAVER1 | 1.52e-04 | 330 | 175 | 11 | int:DTX2 |
| Interaction | FHL3 interactions | 1.55e-04 | 276 | 175 | 10 | int:FHL3 | |
| Interaction | KLF9 interactions | 1.61e-04 | 93 | 175 | 6 | int:KLF9 | |
| Interaction | MAPRE1 interactions | EPS15 REPS1 TRIO ERC1 PLEKHA4 TACC2 TTBK1 PRRC2C SVIL LPP SEC16A EIF3A TACC3 MTUS2 | 1.65e-04 | 514 | 175 | 14 | int:MAPRE1 |
| Interaction | CBY2 interactions | 1.80e-04 | 135 | 175 | 7 | int:CBY2 | |
| Interaction | SINHCAF interactions | 1.80e-04 | 135 | 175 | 7 | int:SINHCAF | |
| Interaction | HDAC2 interactions | HSPG2 KDM5B IKZF2 FOXK2 TRIO KDM5A MAP3K20 PLEKHA4 MCCC1 ZHX2 WNK1 DENND4C PRRC2C RECQL4 LPP HDAC10 SAP130 RAI1 RAVER1 | 1.94e-04 | 865 | 175 | 19 | int:HDAC2 |
| Interaction | APPL1 interactions | 1.95e-04 | 182 | 175 | 8 | int:APPL1 | |
| Interaction | YWHAB interactions | KDM5B ARHGAP32 HDAC5 ERC1 MAP3K20 PLEKHA4 TSC1 ARHGEF17 WNK1 YWHAE DENND4C TBC1D10B SHROOM1 ATXN1 SVIL RECQL4 PHACTR4 SAP130 FRMD5 TNS3 OTOG | 1.98e-04 | 1014 | 175 | 21 | int:YWHAB |
| Interaction | KDM1A interactions | EPS15 KDM5B HDAC5 ACACB ZFYVE16 KDM5A ERC1 PLEKHA4 TSC1 MCCC1 ANKHD1 TRIM24 BIRC6 DENND4C ATXN1 RECQL4 SEC16A KIAA1958 TACC3 NPAT | 2.02e-04 | 941 | 175 | 20 | int:KDM1A |
| Interaction | PUM1 interactions | RBMS2 PLEKHA4 SAV1 TRIM24 YWHAE ATXN1 PRRC2C SEC16A BICC1 RAVER1 | 2.13e-04 | 287 | 175 | 10 | int:PUM1 |
| Interaction | ATG5 interactions | EPS15 REPS1 TRIO ATG7 MAP6 ANKHD1 WNK1 ATXN1 MDC1 SEC16A RAVER1 | 2.18e-04 | 344 | 175 | 11 | int:ATG5 |
| Interaction | SNTB1 interactions | 2.18e-04 | 63 | 175 | 5 | int:SNTB1 | |
| Interaction | UBQLN3 interactions | 2.24e-04 | 3 | 175 | 2 | int:UBQLN3 | |
| Interaction | MED27 interactions | 2.66e-04 | 102 | 175 | 6 | int:MED27 | |
| Cytoband | 7q32-q34 | 1.51e-05 | 2 | 179 | 2 | 7q32-q34 | |
| Cytoband | 1p32 | 1.59e-04 | 27 | 179 | 3 | 1p32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 3.07e-04 | 325 | 179 | 7 | chr9q34 | |
| GeneFamily | Plexins | 1.89e-05 | 9 | 112 | 3 | 683 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.45e-05 | 161 | 112 | 7 | 593 | |
| GeneFamily | PHD finger proteins | 2.41e-04 | 90 | 112 | 5 | 88 | |
| GeneFamily | CD molecules|Mucins | 2.84e-04 | 21 | 112 | 3 | 648 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 4.26e-04 | 24 | 112 | 3 | 485 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.48e-04 | 66 | 112 | 4 | 722 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.22e-04 | 181 | 112 | 6 | 694 | |
| GeneFamily | AT-rich interaction domain containing | 3.79e-03 | 15 | 112 | 2 | 418 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPS15 KDM5B FOXK2 TRIO VEZF1 ZFYVE16 KDM5A BAZ2B ERC1 STIL ZHX2 TRIM24 PIKFYVE FBXL7 BBX ATXN1 PRRC2C SYNE2 NFYC STK39 EIF3A QKI MN1 ZNF292 SOS1 NPAT | 1.49e-10 | 856 | 177 | 26 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | EPS15 FOXK2 TRIO KDM5A BAZ2B STIL ZHX2 PIKFYVE FBXL7 BBX PRRC2C NFYC STK39 QKI ZNF292 SOS1 | 1.24e-07 | 466 | 177 | 16 | M13522 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KDM5B IKZF2 HDAC5 TRIO MAP6 BAZ2B DTNA HIPK2 CILK1 CHADL DCC ANKHD1 FOCAD TGFB3 TTBK1 NDRG1 PRRC2C NCAN SVIL LSM11 QKI FRMD5 PLXNB1 PLXNB3 | 4.39e-07 | 1102 | 177 | 24 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KDM5B IKZF2 HDAC5 TRIO MAP6 BAZ2B DTNA HIPK2 CILK1 CHADL DCC ANKHD1 FOCAD TGFB3 TTBK1 NDRG1 PRRC2C NCAN SVIL LSM11 QKI FRMD5 PLXNB1 PLXNB3 | 6.24e-07 | 1124 | 177 | 24 | MM1070 |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP | 7.57e-06 | 195 | 177 | 9 | M8006 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | 8.56e-06 | 198 | 177 | 9 | M6511 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 8.92e-06 | 199 | 177 | 9 | M5564 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 9.28e-06 | 200 | 177 | 9 | M5566 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | EPS15 FOXK2 TRIM24 BIRC6 YWHAE FBXL7 TCERG1 ARFGAP1 SEC16A EIF3A | 1.72e-05 | 272 | 177 | 10 | M15123 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.04e-05 | 169 | 177 | 8 | M39230 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.21e-05 | 180 | 177 | 8 | M8239 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.97e-05 | 300 | 177 | 10 | M8702 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | THSD4 HSPG2 HDAC5 TRIO ZFYVE16 OLFML2B NLGN1 LARP1B WNK1 NOSIP FBXL7 ATXN1 SVIL MRTO4 EIF3A ADAMTS14 QKI MN1 TNS3 | 5.61e-05 | 1009 | 177 | 19 | M157 |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | EPS15 DTNB HIPK2 SAV1 ETV6 CILK1 CHADL WNK1 BBX NDRG1 UNC5C STK39 QKI CNTN2 PLXNB3 TNS3 | 5.63e-05 | 754 | 177 | 16 | M39037 |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP | 6.53e-05 | 199 | 177 | 8 | M4886 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP | 6.53e-05 | 199 | 177 | 8 | M6895 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 7.36e-05 | 323 | 177 | 10 | M9150 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | EPS15 REPS1 TRIO KDM5A SAV1 NCKAP5 WNK1 TRIM24 RFX4 MDC1 SYNE2 KDM2A QKI SAP130 WNK3 ZNF292 SOS1 | 8.46e-06 | 595 | 174 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TBXAS1 SOX5 KDM5A ERC1 DTNA SYT17 FAM78B HIPK2 NCKAP5 NLGN1 STIL TRIM24 MLXIPL CSPG5 SYNE2 RECQL4 KIAA1958 DNAI4 EIF3A QKI WNK3 FRMD5 ZNF292 | 1.94e-05 | 1060 | 174 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | DOCK3 TBXAS1 SOX5 MAP6 KDM5A ERC1 DTNA SYT17 FAM78B HIPK2 NCKAP5 NLGN1 STIL TRIM24 IL22RA1 MLXIPL CSPG5 SYNE2 RECQL4 KIAA1958 DNAI4 EIF3A TNFRSF1B QKI WNK3 FRMD5 ZNF292 | 3.36e-05 | 1414 | 174 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SOX5 EPS15 KDM5A DTNB TASP1 TSC1 LARP1B ANKHD1 TRIM24 BIRC6 BBX SYNE2 LPP SCAPER STK39 EIF3A YME1L1 NPAT | 7.19e-05 | 776 | 174 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | THSD4 SOX5 ARHGAP32 TRIO BAZ2B ERC1 DTNB ETV6 ZHX2 BIRC6 FOCAD ATXN1 LPP SCAPER STK39 SOS1 | 1.51e-16 | 199 | 178 | 16 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | THSD4 DOCK3 ACACB DTNA NCKAP5 TACC2 NLGN1 AQP7 DGLUCY MYLK3 SVIL MTUS2 | 2.01e-11 | 192 | 178 | 12 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | THSD4 TRIO ATG7 ERC1 ETV6 ZHX2 ANKHD1 BIRC6 ATXN1 LPP QKI TNS3 | 2.14e-11 | 193 | 178 | 12 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | THSD4 ACACB DTNA TACC2 NLGN1 AQP7 DGLUCY MYLK3 SVIL QKI MTUS2 | 3.03e-10 | 189 | 178 | 11 | 5e80c47f63980904c4c1ff02c201b67b456a0974 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | THSD4 ACACB DTNA NCKAP5 TACC2 NLGN1 DGLUCY MYLK3 SVIL QKI MTUS2 | 3.21e-10 | 190 | 178 | 11 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | THSD4 ACACB DTNA TACC2 NLGN1 AQP7 DGLUCY MYLK3 SVIL QKI MTUS2 | 3.39e-10 | 191 | 178 | 11 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | KDM5A PRRC2C RECQL4 ARFGAP1 CCNL1 PHACTR4 PABPC1L MRTO4 EIF3A TACC3 ZNF292 | 3.58e-10 | 192 | 178 | 11 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-09 | 185 | 178 | 10 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 4.49e-09 | 187 | 178 | 10 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ACACB HIPK2 NCKAP5 ZHX2 FBXL7 ARHGAP31 QKI PLXNB1 PLXNB3 TNS3 | 4.98e-09 | 189 | 178 | 10 | 37ecbd73408d462b47d7e5611f203143e08a2689 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.24e-09 | 190 | 178 | 10 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | TBXAS1 ACACB NCKAP5 ZHX2 FBXL7 ARHGAP31 QKI PLXNB1 PLXNB3 TNS3 | 5.51e-09 | 191 | 178 | 10 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.79e-09 | 192 | 178 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 SOX5 HSPG2 LAMA3 AQP7 SHROOM1 FBXL7 HMCN2 ARHGAP31 TNFRSF1B | 6.72e-09 | 195 | 178 | 10 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HSPG2 OLFML2B FAM78B AQP7 STAB1 ARHGEF40 ARHGAP31 CD300LG TNS3 | 5.32e-08 | 182 | 178 | 9 | dc55de945c6f78f32eb3a1b3520835eb8417e068 |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HSPG2 OLFML2B FAM78B AQP7 STAB1 ARHGEF40 ARHGAP31 CD300LG TNS3 | 5.32e-08 | 182 | 178 | 9 | 010a7364da46101cb5068891fd7bc712ea8f13bd |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.58e-08 | 183 | 178 | 9 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 7.03e-08 | 188 | 178 | 9 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.03e-08 | 188 | 178 | 9 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.03e-08 | 188 | 178 | 9 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.03e-08 | 188 | 178 | 9 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 7.36e-08 | 189 | 178 | 9 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.36e-08 | 189 | 178 | 9 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | THSD4 SOX5 HSPG2 LAMA3 SHROOM1 FBXL7 HMCN2 ARHGAP31 TNFRSF1B | 7.36e-08 | 189 | 178 | 9 | 6463890d8dbee4bc198f91628a5f784970de786a |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.36e-08 | 189 | 178 | 9 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.70e-08 | 190 | 178 | 9 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.05e-08 | 191 | 178 | 9 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 9.20e-08 | 194 | 178 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.61e-08 | 195 | 178 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.61e-08 | 195 | 178 | 9 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-07 | 196 | 178 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.19e-07 | 200 | 178 | 9 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.19e-07 | 200 | 178 | 9 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-07 | 154 | 178 | 8 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 5.91e-07 | 177 | 178 | 8 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 7.29e-07 | 182 | 178 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-07 | 182 | 178 | 8 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.60e-07 | 183 | 178 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.92e-07 | 184 | 178 | 8 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.25e-07 | 185 | 178 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.25e-07 | 185 | 178 | 8 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-07 | 186 | 178 | 8 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.95e-07 | 187 | 178 | 8 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.95e-07 | 187 | 178 | 8 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.95e-07 | 187 | 178 | 8 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 9.31e-07 | 188 | 178 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 9.31e-07 | 188 | 178 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.31e-07 | 188 | 178 | 8 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.31e-07 | 188 | 178 | 8 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.31e-07 | 188 | 178 | 8 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.31e-07 | 188 | 178 | 8 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-07 | 189 | 178 | 8 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-07 | 189 | 178 | 8 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-06 | 190 | 178 | 8 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-06 | 190 | 178 | 8 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-06 | 190 | 178 | 8 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.05e-06 | 191 | 178 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-06 | 191 | 178 | 8 | 2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-06 | 192 | 178 | 8 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-06 | 193 | 178 | 8 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.13e-06 | 193 | 178 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-06 | 193 | 178 | 8 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.13e-06 | 193 | 178 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 1.23e-06 | 195 | 178 | 8 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-06 | 198 | 178 | 8 | f3346c26b9647a199faf3cd7ab19c3a963dbabc2 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 198 | 178 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.43e-06 | 199 | 178 | 8 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 1.48e-06 | 200 | 178 | 8 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.48e-06 | 200 | 178 | 8 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.48e-06 | 200 | 178 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.48e-06 | 200 | 178 | 8 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 200 | 178 | 8 | 8a4c210a3130f7baedf15ecbc0f4903b97da0352 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 178 | 8 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 6.56e-06 | 174 | 178 | 7 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.89e-06 | 179 | 178 | 7 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.89e-06 | 179 | 178 | 7 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.18e-06 | 180 | 178 | 7 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 8.49e-06 | 181 | 178 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 8.49e-06 | 181 | 178 | 7 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.49e-06 | 181 | 178 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 8.80e-06 | 182 | 178 | 7 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 9.12e-06 | 183 | 178 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.12e-06 | 183 | 178 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-06 | 183 | 178 | 7 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.45e-06 | 184 | 178 | 7 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.45e-06 | 184 | 178 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.45e-06 | 184 | 178 | 7 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.78e-06 | 185 | 178 | 7 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.78e-06 | 185 | 178 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.78e-06 | 185 | 178 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.78e-06 | 185 | 178 | 7 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 186 | 178 | 7 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 186 | 178 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 186 | 178 | 7 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 186 | 178 | 7 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 3.98e-06 | 6 | 174 | 3 | DOID:4479 (implicated_via_orthology) | |
| Disease | Schizophrenia | SOX5 CACNA1B ARHGAP32 MAP6 NLGN1 DCC GRM1 YWHAE MED15 CSPG5 HPS4 NCAN UNC5C TNFRSF1B QKI MAP2K7 WNK3 RAI1 | 5.28e-06 | 883 | 174 | 18 | C0036341 |
| Disease | Acute Myeloid Leukemia, M1 | 1.01e-04 | 125 | 174 | 6 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.01e-04 | 125 | 174 | 6 | C1879321 | |
| Disease | FEV/FEC ratio | THSD4 SOX5 HSPG2 ERC1 MAP3K20 TASP1 ETV6 IFITM2 DCC ARHGEF17 MED15 THADA ARHGAP31 CNTN5 SVIL SYNE2 SCAPER MN1 CNTN2 | 1.25e-04 | 1228 | 174 | 19 | EFO_0004713 |
| Disease | reticulocyte count | FOXK2 DTNB PLEKHA4 LAMA3 ITGAD ZHX2 PLXNB2 BIRC6 PIKFYVE MLXIPL THADA ATXN1 CNTN5 SYNE2 SPOCD1 QKI TNS3 | 1.60e-04 | 1045 | 174 | 17 | EFO_0007986 |
| Disease | Autistic Disorder | 1.69e-04 | 261 | 174 | 8 | C0004352 | |
| Disease | cardiomyopathy (is_implicated_in) | 1.82e-04 | 19 | 174 | 3 | DOID:0050700 (is_implicated_in) | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.01e-04 | 49 | 174 | 4 | EFO_0022256 | |
| Disease | testosterone measurement | DOCK3 SOX5 QPCTL WDR81 VARS2 BIRC6 MLXIPL THADA ARHGEF40 TTBK1 BBX SYNE2 MCM9 SPOCD1 MAP2K7 FRMD5 TNS3 RAI1 SOS1 | 2.01e-04 | 1275 | 174 | 19 | EFO_0004908 |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 2.06e-04 | 4 | 174 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.55e-04 | 148 | 174 | 6 | C0279702 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.94e-04 | 152 | 174 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.42e-04 | 447 | 174 | 10 | C3714756 | |
| Disease | waist-hip ratio | THSD4 FOXK2 QPCTL ATG7 WNK1 RFX4 BIRC6 STAB1 NOSIP MLXIPL DGLUCY THADA BBX CNTN5 SYNE2 RIMS1 MN1 CNTN2 | 3.56e-04 | 1226 | 174 | 18 | EFO_0004343 |
| Disease | neutrophil count, basophil count | 3.84e-04 | 224 | 174 | 7 | EFO_0004833, EFO_0005090 | |
| Disease | cortical surface area measurement | THSD4 SOX5 REPS1 BAZ2B HIPK2 NCKAP5 PLXNB2 RFX4 NOSIP FOCAD THADA FBXL7 ARHGAP31 PRRC2C MDC1 UNC5C TACC3 ZSWIM4 SOS1 | 3.92e-04 | 1345 | 174 | 19 | EFO_0010736 |
| Disease | Periodontal Pocket | 4.21e-04 | 25 | 174 | 3 | EFO_1001393 | |
| Disease | Leukemia, Myelocytic, Acute | 5.84e-04 | 173 | 174 | 6 | C0023467 | |
| Disease | neuroimaging measurement | THSD4 SOX5 NCKAP5 TACC2 DCC ZHX2 PLXNB2 YWHAE DENND4C MLXIPL THADA FBXL7 PRRC2C TACC3 ZSWIM4 RAI1 | 6.21e-04 | 1069 | 174 | 16 | EFO_0004346 |
| Disease | monocyte count | TBXAS1 CRYBG2 BAZ2B IFITM2 WNK1 YWHAE MLXIPL THADA BBX ATXN1 CNTN5 LPP NLRC5 LYL1 MN1 TNS3 RAI1 NPAT | 8.40e-04 | 1320 | 174 | 18 | EFO_0005091 |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 9.46e-04 | 8 | 174 | 2 | EFO_0008309 | |
| Disease | colorectal cancer | THSD4 DOCK3 BCL9L ETV6 WNK1 NDRG1 CNTN5 STK39 BICC1 TNS3 LILRB4 | 9.64e-04 | 604 | 174 | 11 | MONDO_0005575 |
| Disease | mean platelet volume | ARHGAP32 FOXK2 HDAC5 ETV7 SAV1 IFITM2 STIL YWHAE MLXIPL BBX SVIL SYNE2 MCM9 ADGRF3 LYL1 | 1.10e-03 | 1020 | 174 | 15 | EFO_0004584 |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 1.15e-03 | 35 | 174 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | gestational age, parental genotype effect measurement | 1.15e-03 | 35 | 174 | 3 | EFO_0005112, EFO_0005939 | |
| Disease | Manic | 1.19e-03 | 78 | 174 | 4 | C0338831 | |
| Disease | Abnormality of the face | 1.21e-03 | 9 | 174 | 2 | C4025871 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.44e-03 | 206 | 174 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | reticulocyte measurement | FOXK2 DTNB PLEKHA4 ITGAD PLXNB2 BIRC6 YWHAE PIKFYVE MLXIPL ATXN1 CNTN5 SYNE2 SPOCD1 QKI TNS3 | 1.50e-03 | 1053 | 174 | 15 | EFO_0010700 |
| Disease | adiponectin measurement | 1.78e-03 | 146 | 174 | 5 | EFO_0004502 | |
| Disease | obesity (implicated_via_orthology) | 1.79e-03 | 215 | 174 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | reaction time measurement | SOX5 REPS1 NCKAP5 TACC2 DCC YWHAE MLXIPL CNTN5 DNAI4 RIMS1 RAI1 | 1.90e-03 | 658 | 174 | 11 | EFO_0008393 |
| Disease | heart rate response to exercise | 2.09e-03 | 43 | 174 | 3 | EFO_0009184 | |
| Disease | nevus count, cutaneous melanoma | 2.09e-03 | 91 | 174 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | Bipolar Disorder | 2.19e-03 | 477 | 174 | 9 | C0005586 | |
| Disease | polychlorinated biphenyls measurement, gestational serum measurement | 2.19e-03 | 12 | 174 | 2 | EFO_0007042, EFO_0007964 | |
| Disease | subcutaneous adipose tissue measurement | 2.27e-03 | 93 | 174 | 4 | EFO_0004766 | |
| Disease | Neurodevelopmental Disorders | 2.27e-03 | 93 | 174 | 4 | C1535926 | |
| Disease | unipolar depression, bipolar disorder | 2.37e-03 | 156 | 174 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | osteoarthritis, knee | 2.51e-03 | 158 | 174 | 5 | EFO_0004616 | |
| Disease | forced expiratory volume | THSD4 TBXAS1 TASP1 ETV6 STIL DCC ZHX2 ARHGEF17 PLXNB2 MED15 KDM2A MN1 | 2.61e-03 | 789 | 174 | 12 | EFO_0004314 |
| Disease | peak expiratory flow | 2.91e-03 | 498 | 174 | 9 | EFO_0009718 | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 3.00e-03 | 14 | 174 | 2 | EFO_0004736, GO_0031427 | |
| Disease | T wave morphology measurement | 3.00e-03 | 14 | 174 | 2 | EFO_0008398 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 3.04e-03 | 49 | 174 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.04e-03 | 49 | 174 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Parkinson disease | 3.06e-03 | 321 | 174 | 7 | MONDO_0005180 | |
| Disease | eosinophil count | DOCK3 TBXAS1 IKZF2 SYT17 IFITM2 NRROS WNK1 FNDC1 THADA ATXN1 MTF1 LPP SEC16A NLRC5 CD300LG TNFRSF1B RAI1 ZNF292 | 3.12e-03 | 1488 | 174 | 18 | EFO_0004842 |
| Disease | L2 Acute Lymphoblastic Leukemia | 3.22e-03 | 50 | 174 | 3 | C0023453 | |
| Disease | response to simvastatin, total cholesterol change measurement, response to fenofibrate | 3.41e-03 | 51 | 174 | 3 | EFO_0007806, GO_1901557, GO_1903491 | |
| Disease | response to cisplatin | 3.41e-03 | 51 | 174 | 3 | GO_0072718 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 3.41e-03 | 51 | 174 | 3 | EFO_0022242 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 3.45e-03 | 15 | 174 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 3.60e-03 | 52 | 174 | 3 | C0023452 | |
| Disease | pulse pressure measurement | THSD4 TBXAS1 QPCTL ATG7 KDM5A ZC2HC1C PLXNB2 DENND4C FNDC1 TTBK1 FBXL7 ATXN1 MTF1 PHACTR4 LPP BICC1 TNS3 | 3.69e-03 | 1392 | 174 | 17 | EFO_0005763 |
| Disease | mortality | 3.70e-03 | 173 | 174 | 5 | EFO_0004352 | |
| Disease | myeloid white cell count | TBXAS1 IKZF2 IFITM2 MLXIPL THADA BBX NDRG1 ATXN1 CNTN5 NLRC5 PLXNB1 TNS3 ZNF292 | 3.84e-03 | 937 | 174 | 13 | EFO_0007988 |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 3.93e-03 | 16 | 174 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | colorectal mucinous adenocarcinoma | 3.93e-03 | 16 | 174 | 2 | EFO_0009361 | |
| Disease | 4-acetamidobutanoate measurement | 3.93e-03 | 16 | 174 | 2 | EFO_0021003 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.93e-03 | 16 | 174 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | granulocyte count | 4.08e-03 | 254 | 174 | 6 | EFO_0007987 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.15e-03 | 110 | 174 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.15e-03 | 110 | 174 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | factor VII measurement | 4.22e-03 | 55 | 174 | 3 | EFO_0004619 | |
| Disease | platelet crit | IFITM2 ITGAD THADA ARHGEF40 BBX CNTN5 NCAN SVIL EIF3A LYL1 MN1 NPAT RAVER1 | 4.38e-03 | 952 | 174 | 13 | EFO_0007985 |
| Disease | sphingomyelin 14:0 measurement | 4.44e-03 | 17 | 174 | 2 | EFO_0010390 | |
| Disease | Acute myeloid leukemia | 4.44e-03 | 17 | 174 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 4.44e-03 | 17 | 174 | 2 | 601626 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.44e-03 | 17 | 174 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | triglycerides to total lipids in medium HDL percentage | 4.44e-03 | 56 | 174 | 3 | EFO_0022333 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 4.44e-03 | 56 | 174 | 3 | EFO_0022251 | |
| Disease | eosinophil percentage of leukocytes | DOCK3 IKZF2 IFITM2 NRROS WNK1 MLXIPL THADA LPP NLRC5 TNFRSF1B ZNF292 | 4.91e-03 | 746 | 174 | 11 | EFO_0007991 |
| Disease | neutrophil-to-lymphocyte ratio | 4.91e-03 | 185 | 174 | 5 | EFO_0008447 | |
| Disease | Feeding difficulties | 4.97e-03 | 18 | 174 | 2 | C0232466 | |
| Disease | triglycerides to total lipids in large HDL percentage | 5.39e-03 | 60 | 174 | 3 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 5.39e-03 | 60 | 174 | 3 | EFO_0022237 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 5.53e-03 | 19 | 174 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | brain measurement, neuroimaging measurement | 5.54e-03 | 550 | 174 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 5.65e-03 | 61 | 174 | 3 | C1961102 | |
| Disease | cutaneous melanoma | 5.81e-03 | 121 | 174 | 4 | EFO_0000389 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 5.81e-03 | 121 | 174 | 4 | EFO_0004612, EFO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SDIAMTELPPTHPIR | 156 | P62258 | |
| SVLMSPHTVPEEPAL | 756 | Q8IZF5 | |
| GLMVGHQPSTLPPEL | 191 | Q8TER5 | |
| ITPPPVQCHHRLSMT | 3566 | Q9NR09 | |
| RSTPLTHDGQPKEMP | 916 | Q8WY36 | |
| HEVLGQSIMPPAIPE | 131 | O95196 | |
| GNQTPVMPSASPILH | 546 | Q9UIF8 | |
| ASARVVMPPIPRHET | 51 | Q5VT40 | |
| TVPGPRHMALSRTPT | 226 | C9J069 | |
| PPQPRTLPSMVHRVS | 136 | Q8N6T3 | |
| PSPVLPSNLSRGMSI | 1401 | Q9Y4B4 | |
| MIPHTLTLGPPSQVV | 276 | P54253 | |
| HSLIPEERLSPTPSM | 56 | Q9UK58 | |
| PPGLTPVDVHINSMQ | 546 | Q9H694 | |
| RMGSQPPDPNTIVHI | 1066 | Q00975 | |
| GSMVVDTPPTLPRHS | 66 | Q8WXS8 | |
| LSPPTPLTLRNDGVM | 281 | O94779 | |
| NIPAPLHPETTVNMT | 531 | Q5JR59 | |
| ALGTTHTPPVPNTMA | 2181 | Q9HC84 | |
| RPSLPLSSTMHLGPV | 1661 | Q7Z5J4 | |
| MAADVSVTHRPPLSP | 1 | Q8IY67 | |
| PPVSMASTVPHSLRQ | 131 | Q8IUD2 | |
| PRPETTIMRQPPVTH | 256 | P98160 | |
| LTPGMDHPISLQPAS | 321 | Q15434 | |
| AVMPNGTPHPTAAIV | 261 | Q96PU8 | |
| LMESIPHSPGPTRIQ | 246 | Q9NXS2 | |
| PPHMLPVLGSSTVVN | 236 | Q33E94 | |
| PMIISRHLPSVSSLP | 501 | F8W0I5 | |
| PLRMSDLTPVHFTPL | 191 | Q9Y314 | |
| ATMTLPGIHPPTLNQ | 631 | Q9H8H0 | |
| FSTPPRQVLHMPLTA | 961 | Q14207 | |
| HPNRMTVPISITNPD | 1331 | O00763 | |
| MLNLHSGEVPAPVPV | 1011 | Q96PE2 | |
| SVSPPEEHAMPIGRI | 321 | P41212 | |
| DRSTLNEPPIGQMHP | 1071 | P43146 | |
| VHQVPVSMGPRVLPS | 1141 | Q9H2X6 | |
| PRNVLTRMPLHEGSP | 141 | P83369 | |
| PESPVHTEPMGIQGR | 791 | Q14676 | |
| TVSPLPRVMIPTAPH | 791 | Q96JE9 | |
| QPTPAHPVMVDLSGR | 926 | Q16787 | |
| NPAPPMSTVIHIRSE | 36 | Q01629 | |
| QPLMPTGSVPHSGLR | 241 | Q8NHJ6 | |
| QPHISPLTINIPDTM | 176 | Q01167 | |
| LTVMEPPHIEDSGQP | 3496 | Q8NDA2 | |
| EHTMLLEGTANRPPP | 2211 | Q2LD37 | |
| RPPSAPEMLTQHGAQ | 426 | Q9NQG7 | |
| PTTLMEPHRINPGEC | 521 | Q5VYM1 | |
| LGPMHPVDIPLSTAL | 61 | B1ANH7 | |
| HTPSPMASRVPLEAT | 381 | O43157 | |
| GPSPLVIPMNHETDV | 671 | O15031 | |
| NPPGTDHVTVPLALM | 591 | Q9ULL4 | |
| PRHMLGLPSTLFTPR | 71 | O14733 | |
| PAPGHRENAPMTLTT | 66 | Q02505 | |
| TPPRISIHIQEMDTP | 331 | Q32MK0 | |
| RPMPGTHTVTLQCPA | 241 | Q92597 | |
| TPGPSLLSLQMRVTP | 586 | P54098 | |
| TFVPAMTAIHGPPIT | 641 | Q96RN5 | |
| MVTPSPPGNHSLSLE | 1 | Q86UT5 | |
| SPPVSTPVTGHKRMV | 151 | Q93052 | |
| PLQPPTDVSQDPRHM | 206 | Q71SY5 | |
| MEAATTLHPGPRPAL | 1 | Q9UGL1 | |
| LPKMGSHEPTISPLT | 301 | O14520 | |
| TLMHLSPPGRSFLPE | 121 | Q9H6L4 | |
| ITMIPNTIPGIQPLH | 821 | Q8N2Q7 | |
| PAVHIPGQEPLTASM | 521 | Q4VXU2 | |
| LHAPPSSMIRSVPIS | 1586 | A7KAX9 | |
| LMQHPPSTIAEVAPV | 336 | Q9UKS7 | |
| TSPLPMTPILEGSHR | 426 | Q8IZ21 | |
| LSVPPVHSTMPGTVT | 366 | Q9UKI9 | |
| TQTSPEPGTRMNILP | 201 | P29375 | |
| ELHAPLPGMTSLSPL | 401 | Q13952 | |
| QMVLALSPPGHLPTS | 441 | Q86WI3 | |
| GSAPPSPLLTRMHRQ | 1236 | Q86UR5 | |
| TGMCQPIPLHIRPEA | 71 | Q13349 | |
| HPQPMIISRHLPSVS | 676 | E5RHQ5 | |
| PMIISRHLPSVSSLP | 721 | E5RHQ5 | |
| PQPMIISRHLPSVSS | 761 | E5RHQ5 | |
| LVVSSPPRPVRHGDM | 386 | Q9Y6A1 | |
| TSSTHLQLPTPPEVM | 1571 | Q9Y2I7 | |
| MVPSRSCPSITHGPR | 346 | Q7Z6J6 | |
| RHPVIGVLSPQMFPN | 286 | P0CF75 | |
| MTVQTLLGDPAPPLS | 316 | Q969S8 | |
| PHSPTSMLQLIHDPV | 716 | Q9Y2K7 | |
| RMNEPPTSLGLVPHQ | 611 | O95352 | |
| PRGNVLASHSPMSPE | 1646 | Q8IZD9 | |
| ISPVAAMPPLGTHVQ | 11 | Q9Y603 | |
| TPPDPVNGMVHVITD | 556 | P17927 | |
| TPPDPVNGMVHVITD | 1006 | P17927 | |
| TREDAPIGPHLQSMP | 501 | Q14152 | |
| PIGPHLQSMPSEQIR | 506 | Q14152 | |
| TGETVAMVHSPPPTR | 81 | Q9UJT9 | |
| PPGHFSTTPMLSLRQ | 1286 | Q4ZHG4 | |
| MSHGPSPRLAESPQL | 1 | Q96A19 | |
| PMVRSEHVTVPGQPP | 406 | Q8N1P7 | |
| ASVPQPASPLMHIEG | 556 | A8MPP1 | |
| CPRGPIHSILPMTFE | 391 | Q6UWU2 | |
| NVGTTRLSHMPLPPA | 881 | Q86UU0 | |
| RHPTGNSITKSPPLM | 731 | Q5VZ89 | |
| AHIVPPRPLTNMNDT | 331 | O60941 | |
| ENMAVRPAPHPGTVI | 1011 | Q02246 | |
| MHPIEPGDKRPVTSS | 551 | Q9H4E7 | |
| NTIPGMPLHPETDSR | 741 | Q9NYL2 | |
| MPVAGPLVHLSTPRA | 396 | Q96RQ3 | |
| PVISLGHSRPPGVAM | 61 | P12980 | |
| ELEPLGESPHTLSMP | 686 | Q6UXX5 | |
| PQLVATMPVSPAGSH | 36 | Q5VTH9 | |
| SHTISRPIPMPIRSA | 566 | Q9Y4J8 | |
| QMIVHPTPTPIRAGD | 136 | Q8N6P7 | |
| SVQIEGHPMSLPLQP | 501 | Q8N6P7 | |
| HVLTPEMIPPSDRAS | 301 | P42566 | |
| GSVPNIPTEMLPQHR | 336 | Q9UQL6 | |
| LPPQGAISETRMGHP | 76 | Q7Z3D6 | |
| MEGPRSSTHVPLVLP | 1 | Q6NUI6 | |
| IRFSPPGSPSMVVHR | 966 | Q13255 | |
| PGSPSMVVHRRVPSA | 971 | Q13255 | |
| MVVHRRVPSAATTPP | 976 | Q13255 | |
| MSPGRHVIPSPSTDR | 176 | Q9BY12 | |
| NLEIHSTPGPPIEIM | 2541 | Q6ZTR5 | |
| PVPSFLGRSPMHRVT | 1711 | Q5VW36 | |
| AMVHSLPTAVPESPR | 581 | Q659C4 | |
| VPSSLPPHARMLTLD | 51 | Q86YC3 | |
| PHSMEPQLRQLGLPT | 146 | Q9UKD2 | |
| QHTTMATRSPALPPE | 1766 | Q6ZRI0 | |
| GLEPSVGSRHPLMQP | 326 | Q10571 | |
| PAPGHRENAPMTLTT | 66 | Q9H195 | |
| PQSTPVHSPDRMLDS | 876 | Q9NXL9 | |
| SHLRQLMDEPPAPGS | 1046 | Q5ST30 | |
| PGRPVPVATETSSMH | 571 | Q9Y6A5 | |
| LPMQPVPESSDGLLT | 1071 | Q6YHU6 | |
| LSVMPPNGRAQTHTP | 31 | Q9HCN2 | |
| PDTAIVHPVPIRMTP | 446 | Q96D71 | |
| HPVMARLPSPTVARS | 761 | O95425 | |
| LPPPISHDGSRQDMA | 211 | Q9BSW7 | |
| LPQPAESSTHMLLPG | 5456 | Q8WXH0 | |
| TPHFRASAQVVMPPI | 66 | Q5JUQ0 | |
| PRISPSTHEPLEMTS | 1066 | O14513 | |
| MVLLPGPPLESTFHQ | 346 | Q9H4M7 | |
| GPAPVPTNLHLSVSM | 666 | O94761 | |
| DQIHLTINPGSTPMP | 101 | Q14872 | |
| MVPPSISGHSRAPVL | 571 | O14594 | |
| HSPRSQMALTGISPP | 111 | Q9NZC9 | |
| LHGPMRFPPSLSETN | 261 | Q9Y520 | |
| PSIRLVVMHPSVAGP | 56 | A0A1B0GVT2 | |
| LVRMRSPPDPHASQG | 396 | Q2M3G4 | |
| PTFEPIPTHMNALGS | 711 | Q68CZ2 | |
| PHRTPPAPVTEEMLQ | 416 | Q8NA69 | |
| AMHTVPVPPTTVRTD | 446 | Q68BL8 | |
| RPGTMRHPTPLQQEP | 1046 | Q07889 | |
| LGPEVPPASSAMTHL | 336 | Q9NP71 | |
| PRSSQRVPPMGIQHS | 61 | P13385 | |
| PRVPTHTLAMVVPPQ | 716 | Q8IWZ3 | |
| HTLAMVVPPQEPDRT | 721 | Q8IWZ3 | |
| APEGDVISMPPLHTS | 306 | Q6UXG3 | |
| SAMQRVHLAPIPDPS | 566 | Q9UPZ9 | |
| RNLMPSFIRHGPTIP | 31 | Q9H4B6 | |
| PPPLLSGLAMDSHRV | 16 | O15417 | |
| FSPHNSGRPMELQIP | 576 | Q15468 | |
| QHQPSPMARPLTVDE | 316 | P24557 | |
| AGPVTMTSVHPPIRS | 671 | O15164 | |
| SPPTPDSVGQLHIMD | 1141 | Q92574 | |
| SHMLLTTPQVPLAPV | 711 | Q5TCY1 | |
| IAHPVTITSPMNLPT | 476 | Q14119 | |
| PLPLNSTTEAVHMLP | 676 | O15027 | |
| PMIHPQVAIAASPAT | 411 | O14776 | |
| LAPGLHMQLPSVPTQ | 96 | Q6ZMY3 | |
| MGVVLSPHPAPSRRE | 1 | X6R8R1 | |
| MSIIRSNAPGPPLHI | 211 | Q9H0E3 | |
| HPPLMVLQPLFTNTG | 56 | O15391 | |
| PVLHQPPAMSSALGT | 21 | P12018 | |
| TVMPNPTVPPLLHTV | 1526 | O60281 | |
| PNLGPLRTMHGTPIS | 1811 | Q9NY15 | |
| METGTAPLVAPPRRH | 1 | Q4KMP7 | |
| LHTDRESPRPGPSML | 1816 | O95359 | |
| NSLPEIVPPMGTLFH | 271 | Q2M1Z3 | |
| STVPSGLPLPILMHL | 61 | Q86TA4 | |
| LPVGVMLPHNTTEAP | 11 | Q53FD0 | |
| IMPRGPTLGHVSLLP | 621 | Q96TA2 | |
| QDTLGHVMPSVQLPP | 236 | Q9Y6X8 | |
| SPTSPHMPALRINSG | 411 | P35711 | |
| TRSMAPGAVHLPQPV | 206 | P20333 | |
| IHSTVLSPPMPTEVL | 971 | Q9H4A3 | |
| VIMGTNAISPQVPPH | 526 | Q6ZMP0 | |
| MAEPSGSPVHVQLPQ | 1 | Q9UEW8 | |
| TSPGPIPITLAMEHV | 1336 | Q6BDS2 | |
| PPGALLTRPVVLTMH | 596 | O95185 | |
| DHGIPSCPPNIMTTR | 176 | Q9H6P5 | |
| PDQPSSLMRQHVSVP | 151 | Q9H347 | |
| LRLTSPPEPTVMTHV | 51 | P10600 | |
| PLTAVAVMPAPHTSI | 1741 | Q562E7 | |
| PPASVASLQPHMIGA | 1746 | O75962 | |
| PLSPDVPMTVNTVDH | 901 | Q7Z3T8 | |
| GEPHPSPLDSIMSNR | 581 | Q9H7M6 | |
| SPPSLQHSMSAVPGR | 886 | Q9BYP7 | |
| PHGMSASPSVISRPI | 266 | Q8N8K9 |